Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricZBHZimmer BiometSTESterisRVTYRevvity
Snapshot
Price$87.09$200.40$99.04
Market cap$17.28B$19.75B$11.16B
Valuation
P/E22.4x25.3x46.8x
Forward P/E26.2x19.8x52.4x
Growth
Revenue growth9.2%8.7%4.8%
EPS growth-14.6%27.9%-10.7%
Profitability
Net margin9.1%13.2%8.3%
ROE6.0%11.1%3.3%
Balance sheet & cash
Debt / equity0.59x0.27x0.44x
Free cash flow yield7.5%5.4%5.1%
Dividend yield1.0%1.2%0.3%
Verdict
Investment ratingNeutral· 50Favorable· 59Weak· 33

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearZBHtoday $87STEtoday $200RVTYtoday $99
2027$66.62 – $97.71+12% CAGR$192.31 – $282.05+41% CAGR$75.77 – $111.12+12% CAGR
2028$67.96 – $99.67+7% CAGR$246.06 – $360.89+34% CAGR$77.28 – $113.35+7% CAGR
2029$69.32 – $101.66+5% CAGR$314.83 – $461.75+32% CAGR$78.83 – $115.61+5% CAGR
2030$70.70 – $103.70+4% CAGR$402.83 – $590.82+31% CAGR$80.40 – $117.92+4% CAGR
2031$72.12 – $105.77+4% CAGR$515.42 – $755.95+30% CAGR$82.01 – $120.28+4% CAGR
5-yr CAGR-3.7% – 4.0%20.8% – 30.4%-3.7% – 4.0%